GENE ONLINE|News &
Opinion
Blog

Bio Japan 2021 Highlights: The Commercialization of iPS Cells and the Key to Improving Clinical Trials

by Aurora Mau
Share To
One of the most critical international biotechnology conferences, Bio Japan, invited professor Shinya Yamanaka over the Regenerative Medicine Japan to share the application of regenerative medicine and the latest developments in induced pluripotent stem (iPS) cells. Professor Shinya Yamanaka is a 2012 Physiology or Medicine Nobel Prize winner, and his research mainly focuses on iPS cells.

It's free! Log in now to read

LATEST
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
2022-07-05
Breakthrough Zebrafish Genome Database Now Available
2022-07-05
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Sanofi Launches Nonprofit Brand To Distribute Medicines to Low-Income Countries
2022-07-05
As Private Equity Sale Becomes Less Likely, Novartis May Gravitate Towards Sandoz Spinoff
2022-07-04
Ascletis Begins Study of PD-L1 Antibody Candidate Against HIV
2022-07-04
Akebia Therapeutics Gains $55M Following Deal Termination by Otsuka Pharmaceutical
2022-07-04
EVENT
2022-07-27
BIO Asia–Taiwan 2022
Online and on-side
2022-08-03
BIOPLUS-INTERPHEX KOREA
Seoul
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
Scroll to Top